This brand name is authorized in Turkey.
The drug FERRISITA contains one active pharmaceutical ingredient (API):
1
|
UNII
63G354M39Z - FERRIC CITRATE ANHYDROUS
|
|
Ferric citrate is a phosphate binder and iron replacement product. It is used for the control of serum phosphorus levels and the treatment of iron deficiency anemia in adult patients with chronic kidney disease on dialysis. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| B03AB | Iron trivalent, oral preparations | B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8698747570010 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.